
Ginkgo Bioworks Holdings Inc
-14.12 %
1086.07 %
Yet to be announced
Company Overview
Ginkgo Bioworks Holdings Inc is a biotechnology company that specializes in using genetic engineering to produce bacteria with industrial applications. The company designs and prints DNA to engineer organisms for various applications in fields including pharmaceuticals, agriculture, and industrial chemicals. Their platform enables customers to program cells as easily as we can program computers.
The company develops engineered organisms that can produce rare molecules and proteins that would otherwise be difficult or impossible to extract from nature or synthesize with conventional methods. Their technology has applications in diverse fields including food, agriculture, pharmaceuticals, and materials production.
Revenue Sources
PassBased on review of Ginkgo Bioworks' revenue sources, their primary income comes from bioengineering services and product development through their cell programming platform. Their business model focuses on engineering organisms for various industrial and commercial applications. None of their reported revenue streams appear to derive from inherently haram products or services.
Reliance on Interest
Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
Sept. 30, 2024 | $89.05m | $144.25m | - | - | 0.00% | 0.00% |
June 30, 2024 | $56.21m | $268.84m | - | $-10,000,000.0 | 0.00% | 3.84% |
March 31, 2024 | $37.94m | $204.24m | - | $-12,000,000.0 | 0.00% | 5.73% |
Dec. 31, 2023 | $34.76m | $256.88m | - | $44.01m | 0.00% | 17.13% |
Interest income has been consistently reported as zero across all examined quarters. Interest expense has fluctuated but remains relatively small compared to total expenses. Additionally, the company is still in its growth phase and not yet fully mature in its operations, as evidenced by the significant gap between revenues and expenses. Therefore, we can conclude that interest is not a material part of their business model.
Operational Ethics
PassAfter reviewing available public information, SEC filings, and company statements, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company's operations are primarily based in the United States, and there are no documented current material relationships with the state of Israel or the Chinese Communist Party.
Login to join the discussion